Create Medicines raises $122M to bolster in vivo CAR-T therapies

Create Medicines raises $122M to bolster in vivo CAR-T therapies is a pharma and life sciences industry update from BioPharma Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Delilah Alvarado · 2026-05-14

The fresh funds will support the biotech's pipeline of RNA-based CAR-T cell therapies for cancer and autoimmune conditions.

Source: BioPharma Dive